BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15633395)

  • 21. [Diagnosis and treatment of tumor metastases].
    Petruzelka L
    Vnitr Lek; 2001 Aug; 47(8):555-60. PubMed ID: 15633397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
    Ong TA; Winkler MH; Savage PM; Seckl MJ; Christmas TJ
    BJU Int; 2008 Jul; 102(2):198-202. PubMed ID: 18294302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution.
    Crompton BD; Goldsby RE; Weinberg VK; Feren R; O'Donnell RJ; Ablin AR
    Pediatr Blood Cancer; 2006 Sep; 47(3):255-9. PubMed ID: 16123980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.
    Burcombe R; Wilson GD; Dowsett M; Khan I; Richman PI; Daley F; Detre S; Makris A
    Breast Cancer Res; 2006; 8(3):R31. PubMed ID: 16790076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intensified chemotherapy of solid tumours].
    Vyzula R
    Vnitr Lek; 2001 Aug; 47(8):553-4. PubMed ID: 15633396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy in breast cancer.
    Charfare H; Limongelli S; Purushotham AD
    Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic?
    Bonnefoi H; Underhill C; Iggo R; Cameron D
    Eur J Cancer; 2009 Jul; 45(10):1733-43. PubMed ID: 19477634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
    Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.
    Collette L; Bosset JF; den Dulk M; Nguyen F; Mineur L; Maingon P; Radosevic-Jelic L; Piérart M; Calais G;
    J Clin Oncol; 2007 Oct; 25(28):4379-86. PubMed ID: 17906203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why does cytotoxic chemotherapy cure only some cancers?
    Savage P; Stebbing J; Bower M; Crook T
    Nat Clin Pract Oncol; 2009 Jan; 6(1):43-52. PubMed ID: 18982000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expectations from cytotoxic chemotherapy.
    Tattersall MH
    Aust N Z J Surg; 1982 Aug; 52(4):335-40. PubMed ID: 6180722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.
    Savage P
    BMC Cancer; 2015 Jan; 15():11. PubMed ID: 25605631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for solid tumours. Routine treatment not yet justified.
    Mead GM
    BMJ; 1995 Jan; 310(6974):246-7. PubMed ID: 7866133
    [No Abstract]   [Full Text] [Related]  

  • 36. Shifting the cancer paradigm: must we kill to cure?
    Schipper H; Goh CR; Wang TL
    J Clin Oncol; 1995 Apr; 13(4):801-7. PubMed ID: 7707104
    [No Abstract]   [Full Text] [Related]  

  • 37. On the (so-called) Spontaneous Disappearance of Solid Abdominal Tumours; with Three Cases.
    Smith JG
    Med Chir Trans; 1894; 77():139-49. PubMed ID: 20896842
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possibilities of curative chemotherapy of solid tumours].
    Abrahámová J
    Vnitr Lek; 2001 Aug; 47(8):548-52. PubMed ID: 15633395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
    Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
    Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medical treatment of solid tumours].
    Buter J
    Ned Tijdschr Tandheelkd; 2008 Apr; 115(4):201-2. PubMed ID: 18512518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.